Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

RSS icon
Thumbnail

ACC announces late-breaking clinical trials for annual scientific session

The American College of Cardiology (ACC) announced the late-breaking clinical trials sessions for its 65th annual scientific session. The conference is taking place from April 2 to 4 at the McCormick Place convention center in Chicago.

Novartis agrees to pay-for-performance agreements with insurers to cover heart failure drug

Novartis has entered into a pay-for-performance agreement with Cigna to cover sacubitril/valsartan (Entresto), a twice-daily oral medication to treat patients with heart failure and reduced ejection fraction. Aetna also signed a value-based agreement with Novartis based on the drug having similar results as shown in clinical trials, according to a Reuters report.

Thumbnail

CMS releases national coverage determination for Watchman and other LAA devices

The Centers for Medicare & Medicaid Services (CMS) released its final national coverage determination on Feb. 8 for percutaneous left atrial appendage closure for non-valvular atrial fibrillation.

Abiomed’s quarterly revenue increases 38%

Led by strong sales of its Impella heart pump, Abiomed’s revenue for the fiscal third quarter of 2016 increased 38 percent to $85.8 million compared with the same time period in 2015.

FDA grants Spectranetics bridge occlusion balloon 510(k) clearance

The FDA granted Spectranetics 510(k) clearance on Feb. 8 for its bridge occlusion balloon for temporary vessel occlusion in cardiac lead extraction procedures.

Thumbnail

Spectranetics Receives FDA 510(k) Clearance for Bridge™ Occlusion Balloon for Lead Extraction Procedures

Life-Saving Technology Designed for Safety, Stability and Procedural Control.

Thumbnail

Edwards Lifesciences’ TAVR sales increase 25 percent in fourth quarter

Led by strong sales in its transcatheter heart valve therapy (THV) division, Edwards Lifesciences’ fourth quarter revenue in 2015 increased 8.6 percent and its GAAP earnings per share increased 28.0 percent compared with the same period a year earlier.

Pediatric hospital stops conducting elective heart surgeries pending internal review

St. Christopher's Hospital for Children in Philadelphia announced on Feb. 1 that it had had stopped conducting elective heart surgeries pending an internal review, the Philadelphia Inquirer reports. 

Displaying 6577 - 6584 of 10742

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.